Showing 1821-1830 of 2150 results for "".
- eSight Names New Senior Leadershiphttps://modernod.com/news/esight-names-new-senior-leadership/2481562/eSight announced the selection of John Tushar as the new Chairman of the Board; Aaron Tutwiler as the new CEO; and Roland Mattern as Director of Sales and Marketing. In these new roles, the three senior leaders will drive forward the execution of the company’s long-term
- Iridex Announces US Launch of Next Generation PASCAL Laser with MicroPulsehttps://modernod.com/news/iridex-launches-next-gen-pascal-laser-with-micropulse-in-us/2481542/Iridex announced the full market launch of the next generation Iridex PASCAL platform. First offered in limited release in late 2022, the PASCAL is designed to provide an advanced technology package combining fast and precise pattern scanning capabilities, Endpoint Management Techn
- Nidek Launches the NT-1/1e Non Contact Tonometerhttps://modernod.com/news/nidek-launches-the-nt-11e-non-contact-tonometer/2481535/Nidek has announced the launch of the NT-1/1e non contact tonometer models. As an addition to same series that includes the NT-1p, the NT-1/1e non-contact tonometers were developed without the pachymetry function to address market demand. The NT-1p/1 perform fully automated measur
- Haag-Streit Launches New EyeSuite Softwarehttps://modernod.com/news/haag-streit-launches-new-eyesuite-software/2481532/Haag-Streit has announced the launch of EyeSuite software version i9.13, which offers new features for the Eyestar 900’s Anterior Chamber Suite and market-first functionality for the Lenstar Myopia. In addition, it’s existing portfolio of I
- Horus Pharma Group Launches Nordic Subsidiaryhttps://modernod.com/news/horus-pharma-group-launches-nordic-subsidiary/2481515/Horus Pharma, an independent French laboratory specializing in ophthalmology, has opened of a new subsidiary. From its base in Stockholm, Sweden, Horus Pharma Nordic will cover Sweden, Norway, Finland and Denmark. Horus Pharma develops, patents and markets preservative-free ey
- CooperVision Launches Major US Myopia Control Advocacy and Education Campaignhttps://modernod.com/news/coopervision-launches-major-us-myopia-control-advocacy-and-education-campaign/2481474/CooperVision has unveiled a multifaceted consumer and professional marketing campaign to protect children’s vision and advance myopia control education in the United States to kick off Vision Expo East 2023. The “Make Children’s Sight Your Fight” initiative is rooted in ne
- Oculis Announces US Public Listing on Nasdaqhttps://modernod.com/news/oculis-announces-us-public-listing-on-nasdaq/2481444/Starting today, Oculis’ shares will trade on the Nasdaq Stock Market under the ticker symbol "OCS." The listing comes after successfully closing the business combination between European Biotech Acquisition Corp. (EBAC) and Oculis SA. The business combination was un
- Eyenuk Secures the First European Union MDR Certification for Autonomous AI Detection of DR, AMD, and Glaucomahttps://modernod.com/news/eyenuk-secures-the-first-european-union-mdr-certification-for-autonomous-ai-detection-of-diabetic-retinopathy-amd-and-glaucoma/2481377/Eyenuk has been approved to market its EyeArt AI eye screening system in the European Union for the new uses of detecting age-related macular degeneration (AMD) and glaucomatous optic nerve damage. The EyeArt AI system (version 3.0) has been granted a new European Commiss
- Rayner Launches ‘Peer2Peer: The Podcast’ for Clinical Educationhttps://modernod.com/news/rayner-launches-peer2peer-the-podcast-for-clinical-education/2481342/Rayner announced the launch of the latest addition to their Peer2Peer clinical education platform, "Peer2Peer: The Podcast." Topics included in the podcase include the do's and don’ts of implanting toric IOLs; marketing your clinic online; popular
- Neurotech Pharmaceuticals Appoints Scott Hunter as Chief Commercial Officerhttps://modernod.com/news/neurotech-pharmaceuticals-appoints-scott-hunter-as-chief-commercial-officer/2481341/Neurotech Pharmaceuticals announced the expansion of its executive team with the appointment of Scott Hunter as Chief Commercial Officer bringing two decades of eye care experience across both rare disease and specialty markets. “Scott’s appointment as the company&rsquo